Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kathleen K. Schoemaker currently holds 3,553,322 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen K. Schoemaker has been a net buyer of OREX stock. They have purchased $116.9M and sold $69.8M worth of shares.
Kathleen K. Schoemaker's most recent insider trade was on May 4, 2015, when they purchased 277,777 shares at $10.62 per share.
Kathleen K. Schoemaker serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 256 insider transactions totaling $186.7M over their tenure at the company.
Kathleen K. Schoemaker holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kathleen K. Schoemaker has shown a buying trading pattern, with $116.9M in total purchases and $69.8M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kathleen K. Schoemaker was on Mar 19, 2014, when they sold $102.4M worth of CADX shares. This transaction involved 7,313,241 shares at $14.00 per share.
Kathleen K. Schoemaker currently owns 3,553,322 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kathleen K. Schoemaker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathleen K. Schoemaker has 256 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Kathleen K. Schoemaker and 40,000+ other insiders.